Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1844) 1844
Book Review (206) 206
Publication (165) 165
Book Chapter (21) 21
Book / eBook (5) 5
Data Set (3) 3
Conference Proceeding (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1725) 1725
humans (1408) 1408
female (845) 845
male (759) 759
animals (611) 611
c-reactive protein (592) 592
serum amyloid p-component - metabolism (531) 531
middle aged (499) 499
c-reactive protein - metabolism (439) 439
inflammation (435) 435
adult (418) 418
aged (366) 366
serum amyloid p-component - analysis (365) 365
mice (356) 356
immunology (320) 320
proteins (300) 300
biomarkers - blood (275) 275
ptx3 (273) 273
c-reactive protein - analysis (263) 263
serum amyloid p-component - genetics (232) 232
biochemistry & molecular biology (215) 215
serum (215) 215
innate immunity (202) 202
c-reactive protein - genetics (192) 192
expression (190) 190
analysis (166) 166
biomarkers (166) 166
pentraxin 3 (161) 161
disease (157) 157
research (156) 156
enzyme-linked immunosorbent assay (143) 143
cell biology (139) 139
abridged index medicus (137) 137
protein (134) 134
case-control studies (133) 133
amyloid-p component (126) 126
atherosclerosis (126) 126
prognosis (122) 122
mice, inbred c57bl (121) 121
aged, 80 and over (120) 120
medicine, research & experimental (120) 120
risk factors (120) 120
amyloidosis (119) 119
immunohistochemistry (115) 115
proteomics (114) 114
diagnosis (111) 111
pentraxins (111) 111
amino acid sequence (110) 110
article (107) 107
research article (106) 106
acute myocardial-infarction (105) 105
serum amyloid p-component (105) 105
health aspects (102) 102
pathology (102) 102
physiological aspects (102) 102
long pentraxin (101) 101
medicine (101) 101
molecular sequence data (101) 101
cells, cultured (99) 99
biochemical research methods (98) 98
cytokines (98) 98
mass spectrometry (97) 97
multidisciplinary sciences (97) 97
serum amyloid p component (97) 97
cells (96) 96
disease models, animal (94) 94
adolescent (92) 92
plasma (92) 92
serum amyloid a protein - analysis (92) 92
amyloidosis - metabolism (90) 90
protein binding (90) 90
serum amyloid p-component - immunology (90) 90
gene expression (89) 89
mortality (89) 89
serum amyloid a protein - metabolism (89) 89
young adult (89) 89
amyloidosis - pathology (88) 88
medicine, general & internal (88) 88
prospective studies (88) 88
amyloid (84) 84
serum amyloid p-component - chemistry (84) 84
c-reactive protein - immunology (83) 83
time factors (83) 83
amyloid-p-component (82) 82
long pentraxin ptx3 (82) 82
cardiovascular-disease (78) 78
pentraxin-3 (78) 78
acute-phase proteins (77) 77
care and treatment (77) 77
hematology (77) 77
rheumatology (77) 77
systemic amyloidosis (77) 77
alzheimers-disease (74) 74
amyloid - analysis (72) 72
cardiac & cardiovascular systems (72) 72
science (71) 71
neurosciences (70) 70
pentraxin (70) 70
cancer (69) 69
identification (68) 68
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1838) 1838
French (6) 6
Japanese (4) 4
Chinese (3) 3
German (3) 3
Russian (3) 3
Italian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component
by Richards, Duncan B and Cookson, Louise M and Berges, Alienor C and Barton, Sharon V and Lane, Thirusha and Ritter, James M and Fontana, Marianna and Moon, James C and Pinzani, Massimo and Gillmore, Julian D and Hawkins, Philip N and Pepys, Mark B
The New England Journal of Medicine, ISSN 0028-4793, 09/2015, Volume 373, Issue 12, pp. 1106 - 1114
A two-step process, in which circulating levels of amyloid P are reduced and then antiā€“serum amyloid P antibody is given to activate macrophage clearance... 
MEDICINE, GENERAL & INTERNAL | CARDIOVASCULAR MAGNETIC-RESONANCE | QUANTIFICATION | VOLUME | SCINTIGRAPHY | TISSUE | LIVER | SYSTEMIC AMYLOIDOSIS | AL AMYLOIDOSIS | PHARMACOLOGICAL DEPLETION | Liver - pathology | Serum Amyloid P-Component - immunology | Humans | Immunoglobulin G | Middle Aged | Antibodies, Monoclonal - adverse effects | Carboxylic Acids - pharmacokinetics | Pyrrolidines - administration & dosage | Pyrrolidines - adverse effects | Amyloidosis - diagnostic imaging | Dose-Response Relationship, Drug | Carboxylic Acids - adverse effects | Liver - drug effects | Liver - diagnostic imaging | Adult | Carboxylic Acids - administration & dosage | Serum Amyloid P-Component - antagonists & inhibitors | Immunoglobulin Light-chain Amyloidosis | Pyrrolidines - pharmacokinetics | Antibodies, Monoclonal - pharmacokinetics | Amyloidosis - drug therapy | Serum Amyloid P-Component - analysis | Antibodies, Monoclonal - administration & dosage | Radionuclide Imaging | Aged | Infusions, Intravenous | Monoclonal antibodies | Care and treatment | Amyloidosis | Dosage and administration | Immunoglobulins | Kidneys | Mortality | Liver | Inflammation | Scintigraphy | Macrophages | SAP protein | Patients | Lymph nodes | Atrophy | Proteins | Magnetic resonance imaging | Rodents | Giant cells | Drug therapy | Drug dosages | Amyloid P component | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Serum Amyloid P Component (SAP) Interactome in Human Plasma Containing Physiological Calcium Levels
by Poulsen, Ebbe Toftgaard and Pedersen, Kata Wolff and Marzeda, Anna Maria and Enghild, Jan J
Biochemistry, ISSN 0006-2960, 02/2017, Volume 56, Issue 6, pp. 896 - 902
The pentraxin serum amyloid P component (SAP) is secreted by the liver and found in plasma at a concentration of approximately 30 mg/L. SAP is a 25 kDa... 
PROTEIN | FIBRILS | PENTRAXINS | SULFATE | BIOCHEMISTRY & MOLECULAR BIOLOGY | BINDING | HIGH-DENSITY-LIPOPROTEIN | Immunoprecipitation | Humans | Blood Coagulation Factors - isolation & purification | Male | Peptide Fragments - pharmacology | Complement System Proteins - chemistry | Chromatography, High Pressure Liquid | Blood Proteins - metabolism | Complement System Proteins - analysis | Complement System Proteins - metabolism | Antithrombins - pharmacology | Antibodies, Immobilized - metabolism | Calcium - blood | Tandem Mass Spectrometry | Spectrometry, Mass, Electrospray Ionization | Blood Coagulation Factors - analysis | Proteolysis | Blood Proteins - isolation & purification | Adult | Female | Serum Amyloid P-Component - antagonists & inhibitors | Apolipoproteins - isolation & purification | Peptide Fragments - metabolism | Peptide Fragments - isolation & purification | Apolipoproteins - metabolism | Blood Coagulation Factors - chemistry | Blood Proteins - chemistry | Recombinant Proteins - pharmacology | Apolipoproteins - blood | Blood Coagulation Factors - metabolism | Immunity, Innate | Serum Amyloid P-Component - isolation & purification | Serum Amyloid P-Component - analysis | Blood Proteins - analysis | Peptide Fragments - analysis | Peptide Fragments - chemistry | Complement System Proteins - isolation & purification | Apolipoproteins - chemistry | Ligands | Serum Amyloid P-Component - metabolism | Antibodies, Monoclonal - metabolism | Hirudins - pharmacology | Usage | Glycoproteins | Research | Chemical properties | Apolipoproteins | Mass spectrometry | Calcium ions | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Serum amyloid P component: A novel potential player in vessel degeneration in CADASIL
by Nagatoshi, Akihito and Ueda, Mitsuharu and Ueda, Akihiko and Tasaki, Masayoshi and Inoue, Yasuteru and Ma, Yihong and Masuda, Teruaki and Mizukami, Mayumi and Matsumoto, Sayaka and Kosaka, Takayuki and Kawano, Takayuki and Ito, Takaaki and Ando, Yukio
Journal of the Neurological Sciences, ISSN 0022-510X, 2017, Volume 379, pp. 69 - 76
Abstract In cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), granular osmiophilic material (GOM) may play... 
Neurology | NOTCH3 | Serum amyloid P component | CADASIL | Proteomic | Periostin | Granular osmiophilic material | SUBCORTICAL INFARCTS | POLYNEUROPATHY | ALZHEIMERS-DISEASE | NEUROSCIENCES | CLINICAL NEUROLOGY | LEUKOENCEPHALOPATHY | AUTOSOMAL-DOMINANT ARTERIOPATHY | SYSTEMIC AMYLOIDOSIS | ACCUMULATION | PHARMACOLOGICAL DEPLETION | Temporal Arteries - metabolism | CADASIL - pathology | Humans | Middle Aged | Receptor, Notch3 - analysis | Temporal Arteries - pathology | Male | CADASIL - genetics | Serum Amyloid P-Component - analysis | Receptor, Notch3 - biosynthesis | Serum Amyloid P-Component - genetics | Serum Amyloid P-Component - biosynthesis | Aged, 80 and over | CADASIL - metabolism | Female | Receptor, Notch3 - genetics | Aged | Proteins | Viral antibodies | Analysis | Physiological aspects | Antibodies | Liquid chromatography | Annexins | Mass spectrometry | Enzyme-linked immunosorbent assay | Antigen-antibody reactions | Enzymes | Liver | Albumin | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Randomized phase I trial HIV-CORE 003: Depletion of serum amyloid P component and immunogenicity of DNA vaccination against HIV-1
by Borthwick, Nicola J and Lane, Thirusha and Moyo, Nathifa and Crook, Alison and Shim, Jung Min and Baines, Ian and Wee, Edmund G and Hawkins, Philip N and Gillmore, Julian D and Hanke, TomĆ”Å” and Pepys, Mark B
PLoS ONE, ISSN 1932-6203, 05/2018, Volume 13, Issue 5, pp. e0197299 - e0197299
The failure of DNA vaccination in humans, in contrast to its efficacy in some species, is unexplained. Observational and interventional experimental evidence... 
VITRO | MICE | PROTEIN | MULTIDISCIPLINARY SCIENCES | T-CELLS | VACCINES | Immunogenicity, Vaccine | HIV Infections - prevention & control | Humans | Vaccination | AIDS Vaccines - immunology | Vaccines, DNA - immunology | Male | Injections, Intramuscular | AIDS Vaccines - adverse effects | Proof of Concept Study | Serum Amyloid P-Component - analysis | Young Adult | HIV Infections - immunology | HIV-1 - immunology | Vaccines, DNA - adverse effects | Adult | T-Lymphocytes - immunology | Physiological aspects | AIDS vaccines | Genetic aspects | DNA vaccines | Research | Drug delivery systems | Lymphocytes T | Vaccines | SAP protein | Blood plasma | Proteins | Lymphocytes | Transgenic animals | Human immunodeficiency virus--HIV | Amyloid | Pyrrolidine | Deoxyribonucleic acid--DNA | Immunological memory | Immune response | Medical treatment | Carboxylic acids | Epitopes | Immune systems | Medicine | Depletion | Immunogenicity | Adenoviruses | Software | Amyloidosis | Kinetics | Human behavior | Amyloid P component | Methods | Index Medicus | Deoxyribonucleic acid | HIV | DNA | Human immunodeficiency virus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Inflammatory and coagulation biomarkers and mortality in patients with HIV infection
by Kuller, Lewis H and Tracy, Russell and Belloso, Waldo and De Wit, Stephane and Drummond, Fraser and Lane, H. Clifford and Ledergerber, Bruno and Lundgren, Jens and Neuhaus, Jacqueline and Nixon, Daniel and Paton, Nicholas I and Neaton, James D and INSIGHT SMART Study Grp and INSIGHT SMART Study Group and for the INSIGHT SMART Study Group
PLoS Medicine, ISSN 1549-1277, 10/2008, Volume 5, Issue 10, pp. 1496 - 1508
Background In the Strategies for Management of Anti-Retroviral Therapy trial, all-cause mortality was higher for participants randomized to intermittent,... 
C-REACTIVE PROTEIN | CARDIOVASCULAR HEALTH | MEDICINE, GENERAL & INTERNAL | RISK-FACTORS | MYOCARDIAL-INFARCTION | IMMUNE ACTIVATION | LOGISTIC-REGRESSION ANALYSIS | ANTIRETROVIRAL THERAPY | CORONARY-HEART-DISEASE | ENDOTHELIAL FUNCTION | ACTIVATION MARKERS | HIV Infections - blood | Follow-Up Studies | Fibrin Fibrinogen Degradation Products - analysis | Humans | Logistic Models | Male | Survival Rate | Treatment Outcome | Biomarkers - blood | Case-Control Studies | Cause of Death | Inflammation - blood | Serum Amyloid P-Component - analysis | Randomized Controlled Trials as Topic | Multicenter Studies as Topic | Interleukin-6 - blood | Blood Coagulation | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | HIV Infections - mortality | C-Reactive Protein - analysis | Odds Ratio | Serum Amyloid A Protein - analysis | Index Medicus | Assaigs clĆ­nics | Antiretrovirals | Sida | Antiretroviral agents | AIDS (Disease) | Clinical trials | Marcadors bioquĆ­mics | Biochemical markers | Public Health and Epidemiology | Immunology and allergy | Chronic Disease Management | Infectious Diseases | AIDS | Epidemiology | HIV Infection
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text A Cholesterol-Lowering Drug Reduces Ī²-Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease
by Refolo, L.M and Pappolla, M.A and LaFrancois, J and Malester, B and Schmidt, S.D and Thomas-Bryant, T and Tint, G.S and Wang, R and Mercken, M and Petanceska, S.S and Duff, K.E
Neurobiology of Disease, ISSN 0969-9961, 10/2001, Volume 8, Issue 5, pp. 890 - 899
Clinical, epidemiological, and laboratory studies suggest that cholesterol may play a role in the pathogenesis of Alzheimer's disease (AD). Transgenic mice... 
BIOSYNTHESIS | SECRETASE CLEAVAGE | MICE | PRECURSOR PROTEIN | MUTANT PRESENILIN-1 | PLAQUES | APOLIPOPROTEIN-E GENOTYPE | NEUROSCIENCES | BRAIN | MODULATION | PEPTIDE | Brain Chemistry - drug effects | Oxidoreductases - antagonists & inhibitors | Presenilin-1 | Cholesterol - blood | Cholesterol - physiology | Humans | Nerve Tissue Proteins - analysis | Male | Amyloid beta-Protein Precursor - analysis | Membrane Proteins - analysis | Alzheimer Disease - pathology | Protein Processing, Post-Translational - drug effects | Aspartic Acid Endopeptidases | Amyloid Precursor Protein Secretases | Cholesterol - analysis | Female | Drug Evaluation, Preclinical | Disease Models, Animal | Endopeptidases - metabolism | Enzyme Inhibitors - pharmacology | Alzheimer Disease - drug therapy | Mice, Transgenic | Piperazines - therapeutic use | Enzyme Inhibitors - therapeutic use | Piperazines - pharmacology | Protein Processing, Post-Translational - physiology | Serum Amyloid P-Component - analysis | Animals | Anticholesteremic Agents - therapeutic use | Amyloid beta-Peptides - analysis | Oxidoreductases Acting on CH-CH Group Donors | Mice | Anticholesteremic Agents - pharmacology | Alzheimer Disease - blood | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text New Features of Invasive Candidiasis in Humans: Amyloid Formation by Fungi and Deposition of Serum Amyloid P Component by the Host
by Kevin B. Gilchrist and Melissa C. Garcia and Richard Sobonya and Peter N. Lipke and Stephen A. Klotz
The Journal of Infectious Diseases, ISSN 0022-1899, 11/2012, Volume 206, Issue 9, pp. 1473 - 1478
Background. Invasive candidiasis occurs in the gastrointestinal tract, especially in neutropenic patients. We were interested in determining whether invasive... 
Fungi | Aggregation | Candida albicans | Yeasts | Invasive candidiasis | Candida | Neutrophils | Cell adhesion | Cell aggregates | Amyloids | PATHOGENESIS | DIAGNOSIS | INFECTIOUS DISEASES | ADHERENCE PROPERTIES | PROTEIN | GENE | CONGO RED | MICROBIOLOGY | IMMUNOLOGY | SACCHAROMYCES-CEREVISIAE | EXPRESSION | ADHESINS | Microscopy | Plaque, Amyloid - pathology | Candida albicans - chemistry | Humans | Staining and Labeling | Histocytochemistry | Gastrointestinal Diseases - pathology | Candida albicans - metabolism | Candidiasis, Invasive - pathology | Candidiasis, Invasive - microbiology | Gastrointestinal Diseases - microbiology | Serum Amyloid P-Component - analysis | Candidiasis | Glycoproteins | Research | Analysis | Index Medicus | Abridged Index Medicus | Major and Brief Reports
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease
by Mallia, Patrick and Footitt, Joseph and Sotero, Rosa and Jepson, Annette and Contoli, Marco and Trujillo-Torralbo, Maria-Belen and Kebadze, Tatiana and Aniscenko, Julia and Oleszkiewicz, Gregory and Gray, Katrina and Message, Simon D and Ito, Kazuhiro and Barnes, Peter J and Adcock, Ian M and Papi, Alberto and Stanciu, Luminita A and Elkin, Sarah L and Kon, Onn M and Johnson, Malcolm and Johnston, Sebastian L
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 12/2012, Volume 186, Issue 11, pp. 1117 - 1124
Rationale: Chronic obstructive pulmonary disease (COPD) exacerbations are associated with virus (mostly rhinovirus) and bacterial infections, but it is not... 
Bacteria | Chronic obstructive pulmonary disease | Disease exacerbation | Rhinovirus | disease exacerbation | RESPIRATORY VIRUSES | bacteria | AIRWAY INFLAMMATION | NEUTROPHIL ELASTASE | rhinovirus | BIOMARKERS | EPITHELIAL-CELLS | COMMUNITY | ACUTE EXACERBATIONS | RESPIRATORY SYSTEM | CYSTIC-FIBROSIS | INHIBITOR | chronic obstructive pulmonary disease | COPD | CRITICAL CARE MEDICINE | Sputum - cytology | Prognosis | Prospective Studies | Pulmonary Disease, Chronic Obstructive - microbiology | Bacterial Infections - etiology | Humans | Middle Aged | Pulmonary Disease, Chronic Obstructive - virology | Male | Secretory Leukocyte Peptidase Inhibitor - analysis | Antimicrobial Cationic Peptides - metabolism | Coinfection - physiopathology | Polymerase Chain Reaction - methods | C-Reactive Protein - metabolism | Inflammation Mediators - analysis | Statistics, Nonparametric | Adult | Female | C-Reactive Protein - analysis | Secretory Leukocyte Peptidase Inhibitor - metabolism | Severity of Illness Index | Risk Assessment | Coinfection - etiology | Elafin - metabolism | Pulmonary Disease, Chronic Obstructive - complications | Disease Progression | Serum Amyloid P-Component - analysis | Bacterial Infections - physiopathology | Analysis of Variance | Picornaviridae Infections - physiopathology | Aged | Elafin - analysis | Serum Amyloid P-Component - metabolism | Picornaviridae Infections - complications | Cohort Studies | Smoking | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients
by Lundgren, Jens D and Neuhaus, Jacqueline and Babiker, Abdel and Cooper, David and Duprez, Daniel and El-Sa, Wafaa and Emery, Sean and Gordin, Fred and Kowalska, Justyna and Phillips, Anew and Prineas, Ronald J and Reiss, Peter and Sabin, Caroline and Tracy, Russell and Weber, Rainer and Grund, Birgit and Neaton, James D and DAD Study Grp and SMART INSIGHT and Strategies for Management of Anti-Retroviral Therapy/INSIGHT and DAD Study Groups
AIDS (London, England), ISSN 0269-9370, 2008, Volume 22, Issue 14, pp. F17 - F24
BACKGROUND: Two nucleos(t)ide reverse transcriptase inhibitors (NRTIs)--abacavir and didanosine--may each be associated with excess risk of myocardial... 
Myocardial infarction | Cardiovascular disease | Abacavir | Interleukin-6 | cardiovascular disease | INFECTIOUS DISEASES | myocardial infarction | ANTIRETROVIRAL THERAPY | IMMUNOLOGY | interleukin-6 | INDIVIDUALS | VIROLOGY | INFLAMMATION | CARDIOVASCULAR-DISEASE | abacavir | COHORT | CORONARY-HEART-DISEASE | INTERRUPTION | ARTERY-DISEASE | HIV-1 | Didanosine - therapeutic use | Humans | Middle Aged | Male | Risk | Myocardial Infarction - immunology | Reverse Transcriptase Inhibitors - adverse effects | HIV Infections - immunology | Interleukin-6 - blood | Electrocardiography | Adult | Female | Dideoxynucleosides - adverse effects | Dideoxynucleosides - therapeutic use | Myocardial Infarction - virology | Reverse Transcriptase Inhibitors - therapeutic use | C-Reactive Protein - analysis | Myocardial Infarction - etiology | Anti-Retroviral Agents - therapeutic use | Proportional Hazards Models | Biomarkers - blood | Serum Amyloid P-Component - analysis | HIV Infections - complications | HIV Infections - drug therapy | Serum Amyloid A Protein - analysis | Index Medicus | AIDS/HIV
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Isolation and characterization of pharmaceutical grade human pentraxins, serum amyloid P component and Cā€reactive protein, for clinical use
by Pepys, Mark B and Gallimore, J. Ruth and Lloyd, Joanne and Li, Zhanhong and Graham, David and Taylor, Graham W and Ellmerich, Stephan and Mangione, Palma P and Tennent, Glenys A and Hutchinson, Winston L and Millar, David J and Bennett, Gary and More, John and Evans, David and Mistry, Yogesh and Poole, Stephen and Hawkins, Philip N
Journal of Immunological Methods, ISSN 0022-1759, 10/2012, Volume 384, Issue 1-2, pp. 92 - 102
The human pentraxin proteins, serum amyloid P component (SAP) and Cā€reactive protein (CRP) are important in routine clinical diagnosis, SAP for systemic... 
Serum amyloid P component | Good manufacturing practice | Pharmaceutical | Mononuclear cells | Cā€reactive protein | Cytokine | C-reactive protein | BIOCHEMICAL RESEARCH METHODS | IMMUNOLOGY | AA-AMYLOIDOSIS | IN-VITRO | DEPOSITS | PLASMA-CONCENTRATIONS | MICE | SYSTEMIC AMYLOIDOSIS | PROVIDE EVIDENCE | CORONARY-HEART-DISEASE | TARGETED DELETION | PHARMACOLOGICAL DEPLETION | Leukocytes, Mononuclear - metabolism | Humans | Spectrometry, Mass, Electrospray Ionization | Serum Amyloid P-Component - pharmacology | C-Reactive Protein - pharmacology | Female | Interleukin-10 - secretion | Interleukin-8 - secretion | Acute-Phase Proteins - isolation & purification | C-Reactive Protein - analysis | Interleukin-1beta - secretion | Leukocytes, Mononuclear - drug effects | Enzyme-Linked Immunosorbent Assay | Electrophoresis, Polyacrylamide Gel | Mice, Inbred C57BL | Tumor Necrosis Factor-alpha - secretion | Cells, Cultured | Cytokines - secretion | Interleukin-6 - secretion | Serum Amyloid P-Component - isolation & purification | Amyloidosis - blood | Serum Amyloid P-Component - analysis | C-Reactive Protein - isolation & purification | Animals | Acute-Phase Proteins - analysis | Mice | Chromatography, Gel | Acute-Phase Proteins - pharmacology | Index Medicus | ELISA, enzyme linked immunosorbent assay | BVDV, bovine viral diarrhea virus | HIV, human immunodeficiency virus | IS, international standards | HCV, hepatitis C virus | IBRV, infectious bovine rhinotracheitis virus | PBS, phosphate buffered saline | HBsAg, hepatitis B surface antigen | ESIMS, electrospray ionization mass spectrometry | SAA, serum amyloid A protein | SAP, serum amyloid P component | Research Paper | PBMCs, peripheral blood mononuclear cells | CRP, Cā€reactive protein | cGMP, current good manufacturing practice
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Coordinated proteomic signature changes in immune response and complement proteins in acute myocardial infarction: The implication of serum amyloid P-component
by Cubedo, Judit and PadrĆ³, Teresa and Badimon, Lina
International Journal of Cardiology, ISSN 0167-5273, 2013, Volume 168, Issue 6, pp. 5196 - 5204
Abstract Background Patient outcomes after acute myocardial infarction (AMI) are influenced by the combined activation of several distinct interrelated... 
Cardiovascular | Inflammation | Complement | Acute-phase response | Acute myocardial infarction | Immunity | Proteomics | C-REACTIVE PROTEIN | FETUIN | CARDIAC & CARDIOVASCULAR SYSTEMS | ACUTE-PHASE PROTEIN | REPERFUSION | SIALIC-ACID | DISEASE | CARDIOVASCULAR MORTALITY | DYSFUNCTION | INHIBITOR | Myocardial Infarction - epidemiology | Serum Amyloid P-Component - immunology | Prognosis | Acute-Phase Reaction - immunology | Humans | Middle Aged | Complement System Proteins - immunology | Electrophoresis, Gel, Two-Dimensional | Male | Acute-Phase Reaction - metabolism | Complement System Proteins - analysis | Myocardial Infarction - immunology | Complement System Proteins - metabolism | Necrosis - immunology | Inflammation - metabolism | Female | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | Proteomics - methods | Biomarkers - metabolism | Risk Factors | Necrosis - metabolism | Inflammation - immunology | Myocardial Infarction - metabolism | Serum Amyloid P-Component - analysis | Aged | Serum Amyloid P-Component - metabolism | Proteins | Heart attack | Immune response | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Examining serum amyloid P component microheterogeneity using capillary isoelectric focusing and MALDIā€MS
by Weiss, Noah G and Jarvis, Jason W and Nelson, Randall W and Hayes, Mark A
PROTEOMICS, ISSN 1615-9853, 01/2011, Volume 11, Issue 1, pp. 106 - 113
Serum amyloid P component (SAP) is a glycoprotein of interest due to its presence in amyloid plaque formations. As with most glycoproteins, SAP can possibly... 
Glycoproteomics | IEF | Isoforms | Serum amyloid P | HUMAN-PLASMA | FLIGHT MASS-SPECTROMETRY | PROTEIN-ANALYSIS | BIOCHEMISTRY & MOLECULAR BIOLOGY | BIOCHEMICAL RESEARCH METHODS | PATIENT | IDENTIFICATION | Protein Isoforms - metabolism | Humans | Isoelectric Focusing - methods | Protein Isoforms - analysis | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization - methods | Serum Amyloid P-Component - metabolism | Serum Amyloid P-Component - analysis | Alzheimers disease | Rodents | Index Medicus | Isoelectric focusing | Mass spectrometry
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights